Vincera Pharma Inc (VINC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.5391 -0.0275 (-4.85%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.5500 +0.0109 (+2.02%) 19:55 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,207 | -26,200 | -14,650 | -62,984 | -51,724 |
| Depreciation Amortization | 54 | 403 | -183 | 647 | 641 |
| Accounts payable and accrued liabilities | -1,003 | -532 | 2,108 | 1,046 | 2,374 |
| Other Working Capital | -375 | -2,059 | 375 | -1,020 | 720 |
| Other Operating Activity | 4,097 | 2,599 | -742 | 2,707 | 2,202 |
| Operating Cash Flow | $-32,434 | $-25,789 | $-13,092 | $-59,604 | $-45,787 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -11,821 | -10,588 | -4,192 | -42,978 | -20,195 |
| Sale Of Investment | 47,571 | 31,277 | 10,077 | 2,400 | 0 |
| Investing Cash Flow | $35,750 | $20,689 | $5,885 | $-40,578 | $-20,195 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 96 | 96 | 3 | 280 | 242 |
| Financing Cash Flow | $96 | $96 | $3 | $280 | $242 |
| Exchange Rate Effect | 3 | 20 | 30 | 71 | 44 |
| Beginning Cash Position | 11,733 | 11,733 | 11,733 | 111,564 | 111,564 |
| End Cash Position | 15,148 | 6,749 | 4,559 | 11,733 | 45,868 |
| Net Cash Flow | $3,415 | $-4,984 | $-7,174 | $-99,831 | $-65,696 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,434 | -25,789 | -13,092 | -59,604 | -45,787 |
| Free Cash Flow | -32,434 | -25,789 | -13,092 | -59,604 | -45,787 |